FdaApplication

ANDA 203880

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA INC
application_typeANDA
approval_date2023-12-14

Products (1)

ProductActive ingredientStrengthDosage form
CYCLOSPORINECYCLOSPORINE0.05%EMULSION;OPHTHALMIC

1 product